Skip to content
Insurance, Medical Health Aged Care

Flu shot concerns ahead of worrying flu season

April 11, 2025 3 mins read
  • Media:

Doctors are voicing concerns about the declining flu vaccination rate and say Australia faces the perfect storm this winter with an early start to what is expected to be a bad flu season.

 

Flu vaccinations among high-risk groups have been declining in recent years. Last year, only 61% of adults aged more than 65 were protected against the flu, compared to 70% in 2022. Among children under five, years, only a quarter were vaccinated for the flu last year, down from almost a third a few years ago.

 

Bupa Medical Director Dr Tony MacDermott encouraged Australians to book a flu shot between April and May to be covered in time for the expected peak in June and July.

 

There’s been a troubling decline in the number of people receiving the flu vaccine in recent years, and this puts both individual and public health in jeopardy,” Dr MacDermott said.

 

“As the COVID-19 pandemic slips further into people’s memories, we’re seeing an ongoing trend of vaccine complacency – and this is definitely not the year for it.

 

“Australians need to roll up their sleeves for the flu shot – it will potentially save their life, and those around them who are at risk. Getting the flu vaccine is one of the simplest and most effective things you can do to protect yourself, your family, and your community.”

 

Last year was the worst flu season in five years with more than 365,000 reported cases across Australia and more than 4,200 people admitted to hospital.

 

“This year is on track to be even worse, with twice as many flu cases already reported in Australia compared to the same time last year, and the flu season starting earlier than ever,” Dr MacDermott said.

 

One in three telehealth calls to doctors are currently relating to respiratory issues, according to data from Bupa’s digital health platform Blua, where eligible heath insurance customers have access to three telehealth bookings per year with zero out of pocket costs.

 

Dr MacDermott said modelling from the northern hemisphere flu season pointed to a very challenging season ahead. USA recorded the worst season since 2009 and many hospitals in the UK were swamped with flu cases.

 

“The severity of this flu season could result in a very significant number of preventable illnesses, hospitalisations, and even deaths. The flu has already infected tens of thousands of Australians each month in 2025, and that’s before we’ve reached peak flu season,” Dr MacDermott said.

 

“People are slowly losing the good habits learnt during the COVID-19 pandemic, such as getting vaccinated and staying home if you’re sick. These things are as important as ever.”

 

Infants aged six months to five years, adults aged 65 years and above, pregnant women, people with chronic health conditions, and the indigenous community are the most vulnerable groups to the flu. The flu vaccine is available for free for these at-risk groups.

 

Bupa expects to provide more than 52,000 flu vaccinations to organisations across Australia. They will be delivered onsite at workplaces and universities nationally and by our partnering pharmacies across more than 2,400 locations in Australia and New Zealand. 

 

ENDS

 

NOTE TO NEWS DESKS:

 

Interviews available with Bupa Clinical Director Dr Tony MacDermott

 

 

For more information, please contact:
Aleks Devic                                                    
Head of Media (Health Insurance) and Content, Bupa                             
Email:
aleks.devic@bupa.com.au     

Mob: 0412 868 933                                                      

 

 

About Bupa Asia Pacific

Bupa is an international healthcare group which has been committed to a purpose of helping people live longer, healthier, happier lives and making a better world for more than 70 years.

Bupa Asia Pacific operates in Australia, New Zealand and Hong Kong, supporting about 7.3 million customers through a broad range of health and care services including health insurance, aged care, dental, medical, optical and hearing services.

Employing more than 22,000 people in the region, we believe that we can make a real difference to the lives of customers through our values, purpose and the way that we deliver personalised care.

Over the past 17+ years we have invested more than AUD$36 million in partnerships and programs focused on improving health of communities across Australia.



 

 

More from this category

  • Insurance
  • 15/04/2025
  • 22:11
Duck Creek Technologies

Duck Creek Technologies Appoints General Daniel Hokanson, USA, Ret. to Board of Directors

Decorated general brings extensive leadership and policy development expertise to board roleBOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Duck Creek Technologies, the global intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, has announced the appointment of General Daniel Hokanson, USA, Ret. to the company’s board of directors. He brings deep expertise and experience in leading organizations through the development and implementation of detailed strategic policy to Duck Creek’s board.Hokanson is a retired 4-Star General who served as a member of the Joint Chiefs of Staff and the 29th Chief of the National Guard Bureau.…

  • Medical Health Aged Care, National News Current Affairs
  • 15/04/2025
  • 16:12
FARE and Turning Point

Alcohol remains leading cause for drug treatment in Australia

The number of Australians receiving treatment for alcohol continues to eclipse all other drugs, highlighting the urgent need to address the predatory marketing practices of alcohol companies. New data released today by the Australian Institute of Health and Welfare (AIHW) shows alcohol was the principal drug of concern for people seeking treatment in 2023-24, accounting for two in five (42 per cent) of the 219,277 episodes of treatment – compared to amphetamines (26 per cent), cannabis (16 per cent) and heroin (4 per cent). Principal drugs of concern are defined by the AIHW as, ‘the main substance that the client…

  • Contains:
  • Medical Health Aged Care
  • 15/04/2025
  • 15:11
Galderma

Galderma Launches Sculptra® in China, Further Fueling Its Growth Into One of the Fastest Growing Aesthetics Markets

Sculptra®, the first proven regenerative biostimulator, will provide new options for patients in China who are looking for innovative treatments to correct mid-facial volume…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.